Dr. Nashat Gabrail , MD
Specialist • Canton, OH
4875 Higbee Ave Nw
Canton, OH 447182566
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 30, 2006; this date does not establish years in practice.
-
Published CMS data list 22,386 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2350 — Injection, ocrelizumab, 1 mg: 8,400 service units.
- Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 5,750 service units.
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg: 1,720 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 35 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,337 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Procrit (Epoetin Alfa) — 133 prescription fills, including refills.
- Zarxio (Filgrastim-Sndz) — 121 prescription fills, including refills.
- Xarelto (Rivaroxaban) — 80 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 42 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Specialist in Ohio (2024, 133 clinicians with data). Median for this group: 759. Middle half: 234 to 2,086.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 49,118 in 2020 to 22,386 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4875 Higbee Ave Nw
Canton, OH 447182566
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
1984
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
147 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $599,103 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $480,903 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,739 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,502,265 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,450.06 across 58 records.
By nature of payment
- Consulting Fee: $2,853.00 across 2 records.
- Food and Beverage: $1,597.06 across 56 records.
Reporting-company totals (3 largest of 35)
- Bayer Healthcare Pharmaceuticals Inc.: $1,676.39 across 5 records.
- Sanofi and Genzyme US Companies: $1,246.50 across 1 record.
- Exelixis Inc.: $122.84 across 2 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
42 years (graduated 1984)
CMS Doctors and Clinicians data list 1984 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Gabrail has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Gabrail as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Canton and Ohio
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Specialist in Ohio (2024, 133 clinicians with data). Median for this group: 759. Middle half: 234 to 2,086.
Too few clinicians listed under Specialist in Canton have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Specialist in Ohio (2024, 133 clinicians with data). Median for this group: $57,102. Middle half: $22,856 to $145,430.
Too few clinicians listed under Specialist in Canton have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Specialist in Ohio (2024, 133 clinicians with data). Median for this group: $41,169. Middle half: $17,238 to $105,703.
Too few clinicians listed under Specialist in Canton have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Specialist in Ohio (2024, 133 clinicians with data). Median for this group: 515. Middle half: 103 to 1,932.
Too few clinicians listed under Specialist in Canton have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in Ohio (2024, 133 clinicians with data). Median for this group: $65,832. Middle half: $1,756 to $321,579.
Too few clinicians listed under Specialist in Canton have Medicare Part D data for 2024 to compare.
27 active clinicians are listed under Specialist with a practice address in Canton, OH (1,311 in Ohio).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Canton
0% of these 27 clinicians have the CMS telehealth indicator.
18.5% of these 27 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 54% from 49,118 in 2020 to 22,386 in 2024.
- 2020: 49,118
- 2021: 47,405
- 2022: 31,512
- 2023: 30,404
- 2024: 22,386
-
Medicare-allowed amount
Medicare-allowed amount varied from year to year: $618,083 in 2020 and $599,103 in 2024.
- 2020: $618,083
- 2021: $861,897
- 2022: $880,904
- 2023: $799,577
- 2024: $599,103
-
Paid by Medicare
Paid by Medicare varied from year to year: $508,391 in 2020 and $480,903 in 2024.
- 2020: $508,391
- 2021: $701,152
- 2022: $703,254
- 2023: $641,071
- 2024: $480,903
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 21% from 1,686 in 2020 to 1,337 in 2024.
- 2020: 1,686
- 2021: 1,310
- 2022: 1,255
- 2023: 1,179
- 2024: 1,337
-
30-day fills
30-day fills decreased 17% from 2,107 in 2020 to 1,739 in 2024.
- 2020: 2,107
- 2021: 1,674
- 2022: 1,600
- 2023: 1,475
- 2024: 1,739
-
Part D drug cost
Part D drug cost decreased 21% from $4,455,361 in 2020 to $3,502,265 in 2024.
- 2020: $4,455,361
- 2021: $3,591,529
- 2022: $2,054,099
- 2023: $2,895,194
- 2024: $3,502,265
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 87% from $130,268.54 in 2021 to $17,286.54 in 2025.
- 2021: $130,268.54
- 2022: $134,185.32
- 2023: $60,241.02
- 2024: $38,953.38
- 2025: $17,286.54
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 77 records totaling $17,286.54.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Acrotech Biopharma Inc. |
General
Cash or cash equivalent
|
FOLOTYN | Research | $3,630.00 |
| Acrotech Biopharma Inc. |
General
Cash or cash equivalent
|
FOLOTYN | Research | $3,630.00 |
| Acrotech Biopharma Inc. |
General
Cash or cash equivalent
|
FOLOTYN | Research | $3,630.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Consulting Fee
Cash or cash equivalent
|
Vitrakvi | General | $1,606.50 |
| Sanofi and Genzyme US Companies |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,246.50 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $561.96 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $339.29 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $254.46 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $201.03 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $175.00 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $129.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
SARCLISA | General | $109.67 |
| Exelixis Inc. |
Food and Beverage
In-kind items and services
|
CABOMETYX | General | $100.01 |
| AVYXA PHARMA, LLC |
Food and Beverage
In-kind items and services
|
LUTRATE DEPOT | General | $79.17 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $75.00 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $70.00 |
| SpringWorks Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
OGSIVEO | General | $41.75 |
| SOBI, INC |
Food and Beverage
In-kind items and services
|
Vonjo | General | $40.47 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $40.00 |
| SHORLA ONCOLOGY INC. |
Food and Beverage
In-kind items and services
|
IMKELDI | General | $37.63 |
| SOBI, INC |
Food and Beverage
In-kind items and services
|
Doptelet | General | $35.80 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Lenvima | General | $33.33 |
| Invivyd Inc |
Food and Beverage
In-kind items and services
|
PEMGARDA | General | $32.27 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
DARZALEX | General | $32.00 |
| Takeda Pharmaceuticals U.S.A., Inc. |
General
In-kind items and services
|
— | Research | $32.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2350
Injection, ocrelizumab, 1 mg
|
8,400 | 12 | $146.00 | $54.96 |
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
5,750 | 35 | $3.00 | $0.13 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
1,720 | 19 | $3.42 | $0.11 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
536 | 105 | $32.00 | $7.58 |
|
36415
Insertion of needle into vein for collection of blood sample
|
461 | 102 | $8.00 | $7.82 |
|
96367
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
|
430 | 43 | $109.00 | $25.73 |
|
83735
Magnesium level
|
413 | 102 | $28.00 | $6.51 |
|
84100
Phosphate level
|
413 | 102 | $20.00 | $4.61 |
|
80053
Blood test, comprehensive group of blood chemicals
|
411 | 102 | $44.00 | $10.26 |
|
84550
Uric acid level, blood
|
410 | 102 | $20.00 | $4.39 |
|
83615
Lactate dehydrogenase (enzyme) level
|
405 | 101 | $28.00 | $5.87 |
|
82575
Creatinine clearance measurement to test for kidney function
|
402 | 102 | $40.00 | $9.18 |
|
J3480
Injection, potassium chloride, per 2 meq
|
390 | 14 | $2.18 | $0.11 |
|
96375
Injection of additional new drug or substance into vein
|
276 | 45 | $59.00 | $14.03 |
|
J1200
Injection, diphenhydramine hcl, up to 50 mg
|
251 | 61 | $10.00 | $0.81 |
|
96415
Administration of chemotherapy into vein, each additional hour
|
212 | 31 | $107.00 | $25.20 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
200 | 40 | $453.00 | $115.43 |
|
96372
Injection of drug or substance under skin or into muscle
|
157 | 21 | $54.00 | $13.25 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
154 | 63 | $264.00 | $85.51 |
|
96361
Infusion into a vein for hydration, each additional hour
|
133 | 35 | $49.00 | $11.23 |
|
J2920
Injection, methylprednisolone sodium succinate, up to 40 mg
|
124 | 22 | $18.00 | $4.13 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
115 | 46 | $369.00 | $120.77 |
|
96368
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
|
107 | 25 | $76.00 | $17.90 |
|
36430
Transfusion of blood or blood products
|
96 | 14 | $148.00 | $37.91 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
65 | 17 | $239.00 | $56.66 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Procrit | Epoetin Alfa | 133 | 938 | $132,037.47 | 19 |
| Zarxio | Filgrastim-Sndz | 121 | 888 | $106,202.33 | 13 |
| Xarelto | Rivaroxaban | 80 | 3,300 | $55,458.14 | 15 |
| Bortezomib | Bortezomib | 60 | 448 | $8,685.76 | — |
| Ibrance | Palbociclib | 55 | 1,540 | $859,098.60 | — |
| Metoclopramide Hcl | Metoclopramide Hcl | 48 | 800 | $241.17 | 33 |
| Dexamethasone | Dexamethasone | 48 | 1,295 | $836.86 | 17 |
| Imatinib Mesylate | Imatinib Mesylate | 46 | 1,333 | $6,431.28 | — |
| Megestrol Acetate | Megestrol Acetate | 44 | 1,331 | $1,643.60 | 20 |
| Lupron Depot | Leuprolide Acetate | 36 | 1,008 | $71,584.89 | — |
| Warfarin Sodium | Warfarin Sodium | 34 | 2,061 | $247.24 | 11 |
| Allopurinol | Allopurinol | 31 | 1,710 | $129.98 | 14 |
| Exemestane | Exemestane | 31 | 1,020 | $2,443.99 | — |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 1,678 | $921.23 | — |
| Prednisone | Prednisone | 30 | 488 | $110.50 | 14 |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 30 | 440 | $673.30 | 24 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | 1,435 | $218.30 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 28 | 414 | $500.33 | — |
| Eliquis | Apixaban | 28 | 900 | $17,357.51 | — |
| Methotrexate | Methotrexate Sodium | 26 | 944 | $264.92 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 168 | $144.26 | 16 |
| Doptelet | Avatrombopag Maleate | 24 | 804 | $296,615.57 | — |
| Letrozole | Letrozole | 23 | 1,290 | $217.68 | — |
| Ocrevus | Ocrelizumab | 23 | 4,140 | $900,712.19 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 20 | 252 | $181.15 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-04-01NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - HEMATOLOGY/ONCOLOGY
I20050518000580
OH
1658312160
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Nurse Practitioner
Nurse Practitioner
Certified Nurse Practitioner
Career & Practice History
NPI enumerated June 30, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Specialists in Canton
- Dr. Johnson Thottam, MD
- Dr. Nicholas Bisconti, MD
- Dr. Timothy Coblentz, MD
- Dr. G Sicard, MD
- Kelly Fryer-Tisevich, PT
Mailing Address
4875 Higbee Ave Nw
Canton, OH 447182566
Phone: 3304923345